2869954-98-1

2869954-98-1 structure
2869954-98-1 structure
  • Name: Werner syndrome RecQ helicase-IN-3
  • Chemical Name: Werner syndrome RecQ helicase-IN-3
  • CAS Number: 2869954-98-1
  • Molecular Formula: C31H30ClF3N8O5
  • Molecular Weight: 687.07
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage DNA/RNA Synthesis
  • Create Date: 2023-04-04 20:12:57
  • Modify Date: 2024-04-05 19:47:06
  • Werner syndrome RecQ helicase-IN-3 is a potent and orally active werner syndrome recQ helicase (WRN) inhibitor with an IC50 value of 0.06 µM. Werner syndrome RecQ helicase-IN-3 shows antiproliferative activity. Werner syndrome RecQ helicase-IN-3 shows anticancer activity[1].

Name Werner syndrome RecQ helicase-IN-3
Description Werner syndrome RecQ helicase-IN-3 is a potent and orally active werner syndrome recQ helicase (WRN) inhibitor with an IC50 value of 0.06 µM. Werner syndrome RecQ helicase-IN-3 shows antiproliferative activity. Werner syndrome RecQ helicase-IN-3 shows anticancer activity[1].
Related Catalog
Target

IC50: 0.06 µM (WRN)[1]

In Vitro Werner syndrome RecQ helicase-IN-3 (example 96) (0-10 µM; 8-20 days) 显示抗增殖活性,对 SW48,DLD1 WRN-KO 细胞的 GI50s 值分别为 0.06,>10 µM[1]。 Cell Proliferation Assay[1] Cell Line: SW48, DLD1 WRN-KO cells Concentration: 0-10 µM Incubation Time: 8-20 days Result: Showed antiproliferative activity with GI50s of 0.06, >10 µM for SW48, DLD1 WRN-KO cells, respectively.
In Vivo Werner syndrome RecQ helicase-IN-3 (120 mg/kg; daily for 22 days) 在小鼠体内显示出抗癌活性[1]。 Animal Model: Female Crl:NU(NCr)-Foxn1nu -Homozygous nude mice (SW48 xenografts cells)[1] Dosage: 120 mg/kg Administration: P.o.; daily for 22 days Result: Inhibited tumor growth.
References

[1]. Vincent Bordas, et al. Triazolo-pyrimidine analogues for treating diseases connected to the inhibiton of werner syndrome recq helicase (wrn). WO2022249060A1.

Molecular Formula C31H30ClF3N8O5
Molecular Weight 687.07